For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240131:nRSe5035Ba&default-theme=true
RNS Number : 5035B Samsung Electronics Co. Ld 31 January 2024
Transaction with Affiliate Company
Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on January 31,
2024, announced that its Board of Directors has authorized the following
related-party transaction with an affiliated company.
Trademark License Agreement
- Grant trademark license to Samsung Medison
□ Major Transaction Terms
Transaction Item License fee for use of trademark
Transaction Date February 1, 2021
Transaction Period February 1, 2021-January 31, 2024
Transaction Value KRW 6.6 billion
(total transaction value: KRW 6.6 billion)
Contract Type -
Other information - The cumulative transaction value up to end-2022 was less than the threshold
for Board approval of KRW 5 billion. However, when adding the total value for
2023, the cumulative value exceeds the threshold, necessitating Board approval
to collect the trademark license fees.
- The transaction date is the date the trade license agreement was made with
Samsung Medison.
- The transaction value is an estimated cumulative amount for the transaction
period (i.e., 3 years) and may change according to Samsung Medison's revenue.
* The license fee is set at 0.5% of Samsung Medison's revenue (excluding
revenue not related to the use of trademark) and shall be paid
every year during the transaction period.
Other Information:
ž Number of Independent Directors Present at the BOD Meeting: 6/6
ž Attendance of Audit Committee: Y
※ This disclosure is in accordance with the Korean Fair Trade Act, which
mandates that a company must disclose
financial and real estate transactions in the event the value of such a
transaction is greater or equal to KRW 5 billion
and the counterparty is a financial affiliate of the party required to
make the disclosure.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END UPDKZGFMVMFGDZG